|
1
|
Peralta C, Jiménez-Castro MB and
Gracia-Sancho J: Hepatic ischemia and reperfusion injury: Effects
on the liver sinusoidal milieu. J Hepatol. 59:1094–1106.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion-from mechanism to translation. Nat Med. 17:1391–1401.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Ni D, Wei H, Chen W, Bao Q, Rosenkrans ZT,
Barnhart TE, Ferreira CA, Wang Y, Yao H, Sun T, et al: Ceria
nanoparticles meet hepatic ischemia-reperfusion injury: The perfect
imperfection. Adv Mater. 31(e1902956)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhai Y, Petrowsky H, Hong JC, Busuttil RW
and Kupiec-Weglinski JW: Ischaemia-reperfusion injury in liver
transplantation--from bench to bedside. Nat Rev Gastroenterol
Hepatol. 10:79–89. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li P, He K, Li J, Liu Z and Gong J: The
role of Kupffer cells in hepatic diseases. Mol Immunol. 85:222–229.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gross O, Thomas CJ, Guarda G and Tschopp
J: The inflammasome: An integrated view. Immunol Rev. 243:136–151.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Swanson KV, Deng M and Ting JP: The NLRP3
inflammasome: Molecular activation and regulation to therapeutics.
Nat Rev Immunol. 19:477–489. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhong Z, Liang S, Sanchez-Lopez E, He F,
Shalapour S, Lin XJ, Wong J, Ding S, Seki E, Schnabl B, et al: New
mitochondrial DNA synthesis enables NLRP3 inflammasome activation.
Nature. 560:198–203. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhuang T, Liu J, Chen X, Zhang L, Pi J,
Sun H, Li L, Bauer R, Wang H, Yu Z, et al: Endothelial Foxp1
suppresses atherosclerosis via modulation of Nlrp3 inflammasome
activation. Circ Res. 125:590–605. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Martínez-García JJ, Martínez-Banaclocha H,
Angosto-Bazarra D, de Torre-Minguela C, Baroja-Mazo A, Alarcón-Vila
C, Martínez-Alarcón L, Amores-Iniesta J, Martín-Sánchez F, Ercole
GA, et al: P2X7 receptor induces mitochondrial failure in monocytes
and compromises NLRP3 inflammasome activation during sepsis. Nat
Commun. 10(2711)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mehto S, Jena KK, Nath P and Chauhan S,
Kolapalli SP, Das SK, Sahoo PK, Jain A, Taylor GA and Chauhan S:
The crohn's disease risk factor IRGM limits NLRP3 inflammasome
activation by impeding its assembly and by mediating its selective
autophagy. Mol Cell. 73:429–445.e7. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mauro AG, Bonaventura A, Mezzaroma E,
Quader M and Toldo S: NLRP3 inflammasome in acute myocardial
infarction. J Cardiovasc Pharmacol. 74:175–187. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ghiringhelli F, Apetoh L, Tesniere A,
Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G,
Ullrich E, et al: Activation of the NLRP3 inflammasome in dendritic
cells induces IL-1beta-dependent adaptive immunity against tumors.
Nat Med. 15:1170–1178. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Li C, Jin Y, Wei S, Sun Y, Jiang L, Zhu Q,
Farmer DG, Busuttil RW, Kupiec-Weglinski JW and Ke B: Hippo
signaling controls NLR family pyrin domain containing 3 activation
and governs immunoregulation of mesenchymal stem cells in mouse
liver injury. Hepatology. 70:1714–1731. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Miyauchi T, Uchida Y, Kadono K, Hirao H,
Kawasoe J, Watanabe T, Ueda S, Okajima H, Terajima H and Uemoto S:
Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric
acid are essential diet restriction benefits against liver injury.
Proc Natl Acad Sci USA. 116:13533–13542. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yue S, Zhu J, Zhang M, Li C, Zhou X, Zhou
M, Ke M, Busuttil RW, Ying QL, Kupiec-Weglinski JW, et al: The
myeloid heat shock transcription factor 1/β-catenin axis regulates
NLR family, pyrin domain-containing 3 inflammasome activation in
mouse liver ischemia/reperfusion injury. Hepatology. 64:1683–1698.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xu Y, Johansson M and Karlsson A: Human
UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized
in mitochondria. J Biol Chem. 283:1563–1571. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang F, Qi Y, Harrison TJ, Luo B, Zhou Y,
Li X, Song A, Huang W and Wang Y: Hepatitis E genotype 4 virus from
feces of monkeys infected experimentally can be cultured in
PLC/PRF/5 cells and upregulate host interferon-inducible genes. J
Med Virol. 86:1736–1744. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu W, Chen B, Chen L, Yao J, Liu J, Kuang
M, Wang F, Wang Y, Elkady G, Lu Y, et al: Identification of fish
CMPK2 as an interferon stimulated gene against SVCV infection. Fish
Shellfish Immunol. 92:125–132. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ueta M, Kawai T, Yokoi N, Akira S and
Kinoshita S: Contribution of IPS-1 to polyI: C-induced cytokine
production in conjunctival epithelial cells. Biochem Biophys Res
Commun. 404:419–423. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Goertsches RH, Hecker M, Koczan D,
Serrano-Fernandez P, Moeller S, Thiesen HJ and Zettl UK: Long-term
genome-wide blood RNA expression profiles yield novel molecular
response candidates for IFN-beta-1b treatment in relapsing
remitting MS. Pharmacogenomics. 11:147–61. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
El-Diwany R, Soliman M, Sugawara S,
Breitwieser F, Skaist A, Coggiano C, Sangal N, Chattergoon M,
Bailey JR, Siliciano RF, et al: CMPK2 and BCL-G are associated with
type 1 interferon-induced HIV restriction in humans. Sci Adv.
4(eaat0843)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kommadath A, Bao H, Choi I, Reecy JM,
Koltes JE, Fritz-Waters E, Eisley CJ, Grant JR, Rowland RR, Tuggle
CK, et al: Genetic architecture of gene expression underlying
variation in host response to porcine reproductive and respiratory
syndrome virus infection. Sci Rep. 7(46203)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen YL, Lin DW and Chang ZF:
Identification of a putative human mitochondrial thymidine
monophosphate kinase associated with monocytic/macrophage terminal
differentiation. Genes Cells. 13:679–689. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
National Research Council Committee for
the Update of the Guide for the C and Use of Laboratory A: The
National Academies Collection: Reports funded by National
Institutes of Health. In: Guide for the Care and Use of Laboratory
Animals. National Academies Press (US) Copyright © 2011. National
Academy of Sciences, Washington, DC, 2011.
|
|
26
|
He D, Guo Z, Pu JL, Zheng DF, Wei XF, Liu
R, Tang CY and Wu ZJ: Resveratrol preconditioning protects
hepatocytes against hepatic ischemia reperfusion injury via
Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro
and in vivo. Int Immunopharmacol. 35:201–209. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang X, Mao W, Fang C, Tian S, Zhu X, Yang
L, Huang Z and Li H: Dusp14 protects against hepatic
ischaemia-reperfusion injury via Tak1 suppression. J Hepatol.
S0168-8278:32275–32284. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhai Y, Busuttil RW and Kupiec-Weglinski
JW: Liver ischemia and reperfusion injury: New insights into
mechanisms of innate-adaptive immune-mediated tissue inflammation.
Am J Transplant. 11:1563–1569. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lugrin J and Martinon F: The AIM2
inflammasome: Sensor of pathogens and cellular perturbations.
Immunol Rev. 281:99–114. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
He Q, Li Z, Meng C, Wu J, Zhao Y and Zhao
J: Parkin-dependent mitophagy is required for the inhibition of
ATF4 on NLRP3 inflammasome activation in cerebral
ischemia-reperfusion injury in rats. Cells. 8(897)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Darwesh AM, Keshavarz-Bahaghighat H,
Jamieson KL and Seubert JM: Genetic deletion or pharmacological
inhibition of soluble epoxide hydrolase ameliorates cardiac
ischemia/reperfusion injury by attenuating NLRP3 inflammasome
activation. Int J Mol Sci. 20(3502)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation. Nature.
469:221–225. 2011.PubMed/NCBI View Article : Google Scholar
|
